Stay updated with breaking news from Michael Mcelhaugh. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
(RTTNews) - Arbutus Biopharma (ABUS) issued statement regarding the claim construction ruling of the U.S. District Court for the District of Delaw...
Arbutus Biopharma Corporation (NASDAQ:ABUS) Q4 2023 Earnings Call Transcript February 29, 2024 Arbutus Biopharma Corporation reports earnings inline with expectations. Reported EPS is $-0.12 EPS, expectations were $-0.12. ABUS isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and […]
Operator: Good day, and thank you for standing by. Welcome to the Arbutus Biopharma Corporation Fourth Quarter and Year-End 2022 Financial Results and Corporate Update Conference Call.